These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12412384)

  • 1. Non-myeloablative allogeneic hematopoietic stem cell transplants.
    Fagioli F; Ricchiardi A; Carnevale-Schianca F
    Haematologica; 2002 Aug; 87(8 Suppl):13-9. PubMed ID: 12412384
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation.
    Childs RW
    MedGenMed; 2002 Jun; 4(3):13. PubMed ID: 12466756
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic hemopoietic stem cell transplantation in solid tumors.
    Carnevale-Schianca F; Ricchiardi A; Capaldi A; Bucci AR; Grignani G; Rota-Scalabrini D; Fizzotti M; Aliberti S; Aglietta M
    Transplant Proc; 2005; 37(6):2664-6. PubMed ID: 16182778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse.
    Mattei D; Mordini N; Vigna Taglianti R; Bruno B; Rapezzi D; Gallamini A
    Haematologica; 2005 Jun; 90(6):861-2. PubMed ID: 15951306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programming a hematopoietic stem cell donor: the evolution of a project over time.
    Burgio GR; Locatelli F
    Haematologica; 2006 Aug; 91(8):1015-6. PubMed ID: 16885041
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.
    Rahman S; Hargreaves IP
    Neurology; 2007 May; 68(21):1872; author reply 1872; discussion 1872-3. PubMed ID: 17515557
    [No Abstract]   [Full Text] [Related]  

  • 7. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
    Nakagawa T; Kami M; Hori A; Kim SW; Murashige N; Hamaki T; Kishi Y; Fujimoto H; Matsuoka N; Okajima E; Komiyama M; Tobisu K; Wakayama T; Uike N; Tajima K; Makimoto A; Mori S; Tanosaki R; Takaue Y; Kakizoe T
    Exp Hematol; 2004 Jul; 32(7):599-606. PubMed ID: 15246155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fourth Nagoya International Blood and Marrow Transplantation Symposium: new horizons in allogeneic hematopoietic cell transplantation--2001 revolution.
    Sao H; Morishita Y
    Int J Hematol; 2002 Feb; 75(2):213-7. PubMed ID: 11939273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in unrelated donor hematopoietic cell transplantation: improved matching and use of blood stem cells.
    Anasetti C
    Haematologica; 2002 Aug; 87(8 Suppl):1-3. PubMed ID: 12412381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.
    Tsirigotis P; Bitan RO; Resnick IB; Samuel S; Ackerstein A; Eladì S; Gesundheit B; Zilberman I; Miron S; Leubovic A; Slavin S; Shapira MY
    Haematologica; 2006 Jun; 91(6):852-5. PubMed ID: 16769592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies.
    Kim I; Yoon SS; Lee KH; Keam B; Kim TM; Kim JS; Kim HG; Oh MD; Han KS; Park MH; Park S; Kim BK
    Clin Transplant; 2006; 20(4):496-503. PubMed ID: 16842528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.
    Handgretinger R; Chen X; Pfeiffer M; Mueller I; Feuchtinger T; Hale GA; Lang P
    Ann N Y Acad Sci; 2007 Jun; 1106():279-89. PubMed ID: 17442774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
    Takahashi Y; Childs RW
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation.
    Gillis S; Eisenberg ME; Shapira MY; Or R
    Isr Med Assoc J; 2003 Sep; 5(9):671-3. PubMed ID: 14509163
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in allogeneic hematopoietic stem-cell transplantation.
    Devine SM; Adkins DR; Khoury H; Brown RA; Vij R; Blum W; DiPersio JF
    J Lab Clin Med; 2003 Jan; 141(1):7-32. PubMed ID: 12518165
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.
    Nachbaur D; Larcher C; Kircher B; Eibl G; Nussbaumer W; Gunsilius E; Haun M; Grünewald K; Gastl G
    Ann Hematol; 2003 Oct; 82(10):621-7. PubMed ID: 12920570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.